Skip to main content
main-content

Zeitschrift

Annals of Hematology

Annals of Hematology 2/2021

Ausgabe 2/2021

Inhaltsverzeichnis ( 33 Artikel )

07.01.2021 | COVID-19 | Review Article | Ausgabe 2/2021 Zur Zeit gratis

Hematologic disorders associated with COVID-19: a review

Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta, Ishmael Jaiyesimi

20.10.2020 | Review Article | Ausgabe 2/2021 Open Access

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Maximilian Christopeit, Martin Schmidt-Hieber, Rosanne Sprute, Dieter Buchheidt, Marcus Hentrich, Meinolf Karthaus, Olaf Penack, Markus Ruhnke, Florian Weissinger, Oliver A. Cornely, Georg Maschmeyer

06.11.2020 | Review Article | Ausgabe 2/2021

Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis

Francesco Mannelli

09.11.2020 | Original Article | Ausgabe 2/2021

Clinical association between thyroid disease and immune thrombocytopenia

Shoko Ito, Shin-ichiro Fujiwara, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Tetsuaki Ban, Takashi Nagayama, Kento Umino, Daisuke Minakata, Kaoru Morita, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda

07.11.2020 | Original Article | Ausgabe 2/2021

Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene

Manuel Méndez, María Isabel Moreno-Carralero, Valeria L. Peri, Rafael Camacho-Galán, José M. Bosch-Benítez, Jorge Huerta-Aragonés, Jorge Sánchez-Calero-Guilarte, María Belén Moreno-Risco, Juan Manuel Alonso-Domínguez, María José Morán-Jiménez

03.01.2021 | Original Article | Ausgabe 2/2021

Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities

Ravindra Kumar, Rajiv Yadav, Sweta Mishra, M. P. S. S. Singh, Anil Gwal, Praveen K. Bharti, Shanmugam Rajasubramaniam

06.01.2021 | Original Article | Ausgabe 2/2021

ADAMTS-13–VWF axis in sickle cell disease patients

Valéria Sutana Ladeira, Amanda Rodrigues Barbosa, Marina Mendes Oliveira, Letícia Gonçalves Resende Ferreira, Wander Valadares de Oliveira Júnior, Cristiane de Oliveira Renó, Edna Afonso Reis, Daniel Gonçalves Chaves, Luci Maria Sant’Ana Dusse, Hérica Lima dos Santos, Melina de Barros Pinheiro, Danyelle Romana Alves Rios

07.11.2020 | COVID-19 | Original Article | Ausgabe 2/2021 Open Access

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A. Y. Classen, S. Dolff, B. Grüner, F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J. J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille, on behalf of the LEOSS Study Group

02.11.2020 | Original Article | Ausgabe 2/2021

Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India

Shouriyo Ghosh, Mandira Chakraborty, Sambit Samanta, Nilanjan Sinha, Sandeep Saha, Arnab Chattopadhyay, Siddhartha Sankar Roy, Maitreyee Bhattacharyya

29.10.2020 | Original Article | Ausgabe 2/2021

The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review

Nico Gagelmann, Nicolaus Kröger

10.11.2020 | Original Article | Ausgabe 2/2021

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism

Istemi Serin, Sacide Pehlivan, Ilknur Gundes, Yasemin Fidan Oyaci, Mustafa Pehlivan

07.11.2020 | Original Article | Ausgabe 2/2021

Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)

Anna Mele, Eleonora Prete, Clara De Risi, Stefania Citiso, Giuseppina Greco, Antonietta Pia Falcone, Grazia Sanpaolo, Giuseppe Mele, Angela Giannotta, Carolina Vergine, Giovanni Reddiconto, Giulia Palazzo, Sabrina Sabatelli, Candida Germano, Rosanna Miccolis, Paola Curci, Gaetano Palumbo, Massimo Offidani, Rita Rizzi, Nicola Cascavilla, Domenico Pastore, Nicola Di Renzo, Patrizio Mazza, Giuseppe Tarantini, Attilio Guarini, Silvana Capalbo, Giorgina Specchia, Antonino Greco, Rosa De Francesco, Silvia Sibilla, Lorenzo Tonialini, Maria Rosaria Morciano, Vincenzo Pavone

03.01.2021 | Original Article | Ausgabe 2/2021

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma

Stefania Oliva, Lorenzo De Paoli, Marina Ruggeri, Simona Caltagirone, Rossella Troia, Daniela Oddolo, Mattia D’Agostino, Milena Gilestro, Roberto Mina, Elona Saraci, Gloria Margiotta Casaluci, Elisa Genuardi, Sara Bringhen, Mario Boccadoro, Paola Omedé

02.11.2020 | Original Article | Ausgabe 2/2021

Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma

Jin Mao, Hua Yin, Li Wang, Jia-Zhu Wu, Yi Xia, Hua-Yuan Zhu, Lei Fan, Jian-Yong Li, Jin-Hua Liang, Wei Xu

07.11.2020 | Original Article | Ausgabe 2/2021 Open Access

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes

A. Kasprzak, K. Nachtkamp, M. Kondakci, T. Schroeder, G. Kobbe, A. Kündgen, J. Kaivers, C. Rautenberg, R. Haas, N. Gattermann, N. Bonadies, U. Germing

02.01.2021 | Original Article | Ausgabe 2/2021 Open Access

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis

Ziqing Wang, Weiyi Liu, Mingjing Wang, Yujin Li, Xueying Wang, Erpeng Yang, Jing Ming, Richeng Quan, Xiaomei Hu

07.01.2021 | Original Article | Ausgabe 2/2021

Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA)

Massimo Breccia, Simone Celant, Pier Paolo Olimpieri, Odoardo M. Olimpieri, Fabrizio Pane, Alessandra Iurlo, Alessia Cirilli, Antonietta Colatrella, Lucia Gozzo, Sara Pugliese, Valentina Summa, Paolo Foggi, Paolo Corradini, Pierluigi Russo, on behalf of AIFA Monitoring Registries Group

23.11.2020 | Original Article | Ausgabe 2/2021 Open Access

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125

Yu-Hung Wang, Chien-Chin Lin, Chia-Lang Hsu, Sheng-Yu Hung, Chi-Yuan Yao, Sze-Hwei Lee, Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien

27.10.2020 | Original Article | Ausgabe 2/2021 Open Access

Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow

Nils W. Engel, Jochim Reinert, Nora M. Borchert, Victoria Panagiota, Razif Gabdoulline, Felicitas Thol, Michael Heuser, Walter Fiedler

02.01.2021 | Original Article | Ausgabe 2/2021

Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Qi Chen, Xiao-Lu Zhu, Xin Zhao, Xiao Liu, Hai-Xia Fu, Yuan-Yuan Zhang, Yu-Hong Chen, Xiao-Dong Mo, Wei Han, Huan Chen, Chen-Hua Yan, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

31.10.2020 | Original Article | Ausgabe 2/2021

Preemptive low-dose interleukin-2 or DLI for late-onset minimal residual disease in acute leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Xiao-Lin Yuan, Ya-Min Tan, Ji-Min Shi, Yan-Min Zhao, Jian Yu, Xiao-Yu Lai, Lu-Xin Yang, He Huang, Yi Luo

08.01.2021 | Original Article | Ausgabe 2/2021

Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis

Feiqiong Gao, Jiawei Zhang, Jianlai Hu, Liming Lin, Yang Xu

02.11.2020 | Original Article | Ausgabe 2/2021

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Rebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón, Christelle Ferrà, Jaime Sanz, Anabel Gallardo-Morillo, Abel García-Sola, Anna Torrent, María José Jiménez-Lorenzo, José Luis Piñana, Juan Montoro, Gillen Oarbeascoa, Nieves Dorado, Ignacio Gómez-Centurión, Cristina Muñoz, Carolina Martínez-Laperche, Javier Anguita, Ismael Buño, José Luis Díez-Martín, on behalf of Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH)

07.01.2021 | Original Article | Ausgabe 2/2021

Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings

Yan-Ru Ma, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Ying-Jun Chang, Meng Lv, Chen-Hua Yan, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Xiao-Dong Mo, Xiao-Jun Huang, Yu Wang

06.01.2021 | Original Article | Ausgabe 2/2021 Open Access

Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis

Liwen Wang, Hongxian Xiang, Yuhan Yan, Zuqun Deng, Hui Li, Xin Li, Jing Liu

18.01.2021 | Correction | Ausgabe 2/2021

Correction to: Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis

Liwen Wang, Hongxian Xiang, Yuhan Yan, Zuqun Deng, Hui Li, Xin Li, Jing Liu

16.05.2020 | Letter to the Editor | Ausgabe 2/2021

Primary pulmonary diffuse large B cell lymphoma presenting as bulky bilateral lung tumors

Kyosuke Saeki, Makoto Nakamura, Ryoko Egashira, Kensuke Kojima

16.06.2020 | Letter to the Editor | Ausgabe 2/2021

Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL

Michael J. Hochman, Daniel B. Martin

23.06.2020 | Letter to the Editor | Ausgabe 2/2021 Open Access

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

Anna Hinze, Jenny Rinke, Andreas Hochhaus, Thomas Ernst

04.06.2020 | Letter to the Editor | Ausgabe 2/2021

Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception

Magda Zanelli, Maurizio Zizzo, Francesca Sanguedolce, Giovanni Martino, Lorenzo Brunetti, Stefano Ascani

22.08.2020 | Letter to the Editor | Ausgabe 2/2021 Open Access

Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

Ramona Wullenkord, Christian Reicherts, Jan-Henrik Mikesch, Julia Marx, Klaus Wethmar, Jörn Albring, Simon Call, Georg Lenz, Matthias Stelljes

17.09.2020 | Letter to the Editor | Ausgabe 2/2021 Open Access

Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia

Ke Wan, Yafei Yin, Zimian Luo, Jianzhao Cheng

23.07.2020 | Letter to the Editor | Ausgabe 2/2021 Open Access

Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

Rabia Shahswar, Gernot Beutel, Razif Gabdoulline, Christian Koenecke, Dominik Markel, Matthias Eder, Michael Stadler, Gudrun Gohring, Brigitte Schlegelberger, Arne Trummer, Juergen Krauter, Felicitas Thol, Michael Heuser

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise